Misclassifying the indications for prostate-specific antigen testing may bias case–control studies of the efficacy of prostate cancer screening
2004 ◽
Vol 57
(10)
◽
pp. 1071-1075
◽
2010 ◽
Vol 37
(3)
◽
pp. 441-459
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. e12512-e12512